Navigation Links
Unions Successful in Targeting Healthcare Industry
Date:3/18/2008

DETROIT, March 18 /PRNewswire/ -- The number of representation petitions filed and elections held across all industries declined in 2007, according to data from the National Labor Relations Board (NLRB). Unions successfully continued to organize the nation's healthcare industry, however. IRI Consultants and the American Society for Healthcare Human Resources Administration (ASHHRA) released the data and analysis in the 30th Labor Activity in Healthcare Report.

Unions won 72 percent of representation (RC) elections held in healthcare in 2007 - versus a union win-rate of 62 percent in non-healthcare industries. The success rates for the Service Employees International Union (SEIU), California Nurses Association/National Nurses Organizing Committee (CNA/NNOC) and various state nurses associations were even higher at 79, 80 and 83 percent, respectively. The SEIU accounted for 47 percent of all representation petitions filed in the healthcare industry in 2007.

The states with the highest number of RC petitions filed in healthcare in 2007 include California, Illinois, Michigan, New York, Ohio and Washington. Minnesota, Missouri, Nevada, Oregon and Puerto Rico were the states and territories with the largest percentage increase in RC petition filings.

In addition to analyses of national, regional and state representation and petition data, the report includes articles that review NLRB decisions from 2007 and discuss such legislative issues as nurse-staffing ratios, card-check and so-called neutrality laws. The report also highlights unions' organizing efforts in Texas' healthcare industry and surveys the year's major news stories in the labor movement. These include:

-- The CNA/NNOC joining the AFL-CIO and its partnering with the

Pennsylvania Association of Staff Nurses and Allied Professionals

(PASNAP)

-- Disaffiliation of the state nurses associations of New York, Ohio,

Oregon and Washington from
'/>"/>

SOURCE IRI Consultants
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Are civil unions a 600-year-old tradition?
2. Unions File Charges Against Tenet Healthcare Corporation
3. Unions File Charges Against Tenet Healthcare Corporation, Three Northern California Hospitals
4. Eligard(R) six-month formulation successfully completes European approval procedure
5. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
6. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
7. Bacteria successful in cancer treatment
8. Congress Poised to Add Millions of Uninsured Children to Successful, Bipartisan Health Plan
9. Cell growth technology promises more successful drug development
10. Wacoal Renews Successful Support the Girls Program
11. A New Interactive Consumer Experience Highlighting Successful Weight Loss Strategies is Coming to a Mall Near You
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...lleviates Insurance Claim Processing and Payment C...NTA, Dec. 2 SunTrust Ban...thcare receivables solution for medical and dental...Trust eClaim Revenue Gateway helps providers accel...nt collection and processing so that they can focu...
(Date:12/2/2008)...-- MicroPhage, Inc., http://www.microphage.com ,...ed,the company,s Board of Directors. Taussig was... Research Center in Denver, the nation,s leading i...m 1993 to 2006. His medical specialty,is pediatr...ge extensively and am impressed with its progress,...
(Date:12/2/2008)...to Connect - , , - Only 1 in 4 Teens Report...ngers - , , NEW YORK, Dec. 2 /PRNewswire/ ...ree America and MetLife Foundation shows that many...o communicate with their teens may be missing impo...ut drug and alcohol use. The national survey of mo...
(Date:12/2/2008)...RNewswire-USNewswire/ -- Fatigued medical resident...vision of work hour limits to improve patient safe...w Institute of Medicine report funded by HHS, Agen... The report is the result of a 15-month study by ...tween residents, work schedules, their performance...
Breaking Medicine News(10 mins):Health News:Healthcare Providers Now Able to Perform Real-Time Patient Eligibility Verification 2Health News:Healthcare Providers Now Able to Perform Real-Time Patient Eligibility Verification 3Health News:Healthcare Providers Now Able to Perform Real-Time Patient Eligibility Verification 4Health News:MicroPhage Selects Lynn Taussig, MD for Board of Directors 2Health News:Bridging the Technology Gap: Study Confirms Teens Open to Discussing Drugs and Alcohol With Parents By Email, Cell Phones 2Health News:Bridging the Technology Gap: Study Confirms Teens Open to Discussing Drugs and Alcohol With Parents By Email, Cell Phones 3Health News:New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training 2Health News:New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training 3Health News:New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training 4
...he 10-year international Human Genome Project (HGP...o carry the highest concentration of disease genes...ved to be associated with genetic disease. Over t...ellcome Trust's Sanger Centre, near Cambridge, eas...
...tances we see couples who are HIV sero discordant ...is HIV –1 positive and the wife is negative and th... because sexual intercourse carries a 1 in 500 ris...the female partner and through her to the fetus. ...
...ss what they dream about? Their own rat races! Rea...d by scientists at the Massachusetts Institute of ...ng about rat races and that they might in the long...understand how the human mind works. Most pet...
...ts, doctors in Ohio, the United States of America,...to rid him of a painful ulcer due to a weakened va...time a bovine vein is used in man to treat varicos... Toledo hospital's Jobst Vascular Center at Toledo...
Other Medicine News:Health News:Sperm washing helps couples 2
(Date:12/2/2008)...PRNewswire/ -- Horizon Therapeutics, Inc., a,priv...ced that two pivotal,Phase 3 trials evaluating it...,met all primary endpoints. HZT-501, a novel, pro...g ibuprofen and famotidine, demonstrated a,statis...non-steroidal,anti-inflammatory drug (NSAID)-indu...
(Date:12/1/2008)...AGO, Dec. 2 A study has... new technique for imaging the breast, is not affe...l status, two factors that limit the effectiveness...er. Results will be presented today at the annual ...ca (RSNA). , , "The ability of PEM to dete...
(Date:12/1/2008)...ewswire/ -- S*BIO Pte Ltd today announced the init...potent and orally-active JAK2 inhibitor, in leadin...hronic idiopathic myelofibrosis (CIMF). , , ... tolerability of SB1518 in patients with CIMF and ... 1 part of the study will assess the safety profil...
(Date:12/1/2008)...he Prox1 gene is a two-way switch that, if turned ...ogrammed so that they lose their identity and beco...MPHIS, Tenn., Dec. 1 S... have discovered that a certain differentiated cel...requires the constant expression of a gene called ...
Breaking Medicine Technology:Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Cell Therapeutics Inc 28CTI 29 Prices 241 27 million 28euros 856 000 29 Offering of Common Stock through Societe Generale 2589 1Cell Therapeutics Inc 28CTI 29 Prices 241 27 million 28euros 856 000 29 Offering of Common Stock through Societe Generale 2589 2BioSpecifics Technologies Corp Announces Sale of Stock in Private Placement Offering 2587 1Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer 9536 1Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer 9536 2Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer 9536 3Rwandas Gishwati Forest selected as site for historic conservation project 1899 1Rwandas Gishwati Forest selected as site for historic conservation project 1899 2Rwandas Gishwati Forest selected as site for historic conservation project 1899 3
...RE)--Apr 19, 2007 - Amgen,(NASDAQ: AMGN) today ann...d, double-blind, placebo-controlled, multicenter P...00 previously untreated,patients with extensive-st...um-containing chemotherapy. The study demonstrated...f death (overall,survival Aranesp compared to plac...
...Apr 18, 2007 - Critical,Therapeutics, Inc. (Nasdaq...rch demonstrating a role in chronic inflammatory,a...otein (HMGB1), a,pro-inflammatory mediator and nuc... May 2007 issue of Nature Immunology. The,publicat...es that,can stimulate immune cells to produce pote...
Other Medicine Technology:Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 2Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 3Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 4Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 5Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 6Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 7Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 2Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 3Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 4Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 5
Our high quality therapeutic drug monitoring reagents, calibrators and controls are available for most chemistry analyzers. Reproducible and accurate results for your laboratory needs.
The Emit 2000 Digoxin Calibrators are intended for use with the Emit 2000 Digoxin Assay.
The Newmarket Laboratories RPR kits use carbon particles coated with a mixture of lipid antigens, which will combine with antibody present in patients serum or plasma. The particles are suspended in
For use as a quality assurance reagent in assays detecting IgG and IgM antibodies to Toxoplasma gondii (TOXO IgG and TOXO IgM), IgG and IgM antibodies to rubella virus (rubella IgG and rubella IgM),
Medicine Products: